MeiraGTx Holdings plc

About MeiraGTx Holdings plc

MeiraGTx is a clinical-stage gene therapy company developing viral vector-based treatments for inherited and acquired diseases, including neurodegenerative, ocular, and autoimmune conditions. Its core activities include proprietary vector design, manufacturing, and delivery, with a focus on rare diseases like retinal dystrophies, xerostomia, and Parkinson’s. The company leverages in-house GMP facilities and innovative platforms to provide durable, targeted therapies aimed at high unmet medical needs.